RIP assays indicated that lncRNA LCETRL4 could be markedly enriched in the RNA-protein complexes precipitated with the EIF2S1 antibody as compared with the IgG control in NSCLC cells (P < 0.001) (Fig. 5d). Here, EIF2S1 is linked to non-small cell lung carcinoma.